Investment
Features
FeesSafety
Academy
More
Pluang+

Sranan Gold reports high-grade gold assays up to 39.55 g/t at Lawatino project in Suriname, plans drilling in late 2026.

Market News
10 Sep 2026
Newsfile Corp
View Source
Bullish
Sranan Gold reports high-grade gold assays up to 39.55 g/t at Lawatino project in Suriname, plans drilling in late 2026.

Sranan Gold Corp. announced promising assay results from its Lawatino Gold Project in Suriname, including a high-grade sample of 39.55 grams per tonne gold over 1 meter at the 101 Zone. These findings support the presence of a significant gold-bearing structure along a northwest-southeast trend, aligned with regional shear zones known for gold mineralization. The company is advancing from initial sampling to systematic trenching and channel sampling, aiming to better define the mineralized system. Sranan plans to mobilize drilling equipment to Lawatino in late 2026 to further explore and develop the project.

More News

Gold prices drop over 1% as steady US jobless claims hint at possible Fed rate hike.

Gold prices drop over 1% as steady US jobless claims hint at possible Fed rate hike.

Gold prices fell more than 1% after US data showed initial jobless claims steady at 206,000, indicating a stable labor market. This stability suggests the Federal Reserve may feel confident to raise interest rates in its upcoming policy meeting. The ...

Market News
Bearish
4 hours ago
Breakwave Tanker Shipping ETF soars 3,000% in 2026 amid US-Iran tensions impacting oil transport rates

Breakwave Tanker Shipping ETF soars 3,000% in 2026 amid US-Iran tensions impacting oil transport rates

The Breakwave Tanker Shipping ETF (BWET) surged an extraordinary 3,000% in 2026, rising from $18.73 to $583.39 by September 10. This dramatic increase is linked to escalating hostilities between the U.S., Israel, and Iran, which have driven tanker ra...

Market News
Neutral
4 hours ago
Apnimed advances AD109 for sleep apnea with FDA review and strong financial backing.

Apnimed advances AD109 for sleep apnea with FDA review and strong financial backing.

Apnimed, Inc. is progressing its AD109 drug (Oxnimbi) for obstructive sleep apnea, showing strong Phase 3 results and a clear advantage over CPAP therapy. The company has a fully funded plan for commercialization, with an NDA under FDA review and a P...

Market News
Bullish
4 hours ago
Ethereum eyes $3,050 target after 37% rally, holding key $2,350 support amid $100 oil inflation concerns.

Ethereum eyes $3,050 target after 37% rally, holding key $2,350 support amid $100 oil inflation concerns.

Ethereum is trading around $2,470 following a strong 37% rally in late August, forming a bullish flag pattern that suggests a potential rise to $3,050 if it breaks current consolidation. The $3,050 target aligns with a historical resistance zone, mak...

Technical Signals
Bullish
4 hours ago
Deutsche Bank praises AstraZeneca's lung drug data but rates shares 'sell' with a target of 11,500p.

Deutsche Bank praises AstraZeneca's lung drug data but rates shares 'sell' with a target of 11,500p.

Deutsche Bank acknowledged positive data from AstraZeneca's tozorakimab for chronic obstructive pulmonary disease (COPD), presented at the ERS conference, supporting the drug's commercial potential. Despite this, the bank maintained a 'sell' rating o...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App